-
Eisai contributes to the sustainability of society through ESG (Environmental, Social, Governance) initiatives.
-
-
June 8, 2023
-
June 6, 2023
-
June 2, 2023
EISAI TO PRESENT LATEST DATA ON LEMBOREXANT AT THE 37TH ANNUAL SLEEP 2023 MEETING
-
May 26, 2023
-
May 25, 2023
-
May 26, 2023
IR “Notice of Convocation of the 111st Ordinary General Meeting of Shareholders”
-
May 16, 2023
IR “Annual Financial Results Briefing for the Fiscal Year Ended March 31, 2023 [Material, Webcast]”
-
May 15, 2023
IR “Annual Financial Report for the Fiscal Year Ended March 31, 2023”
-
April 28, 2023
-
April 27, 2023
-
March 9, 2023
Warning Against Solicitation, Fraudulent Emails, etc. that Use the Name of Eisai or Related Parties
-
February 17, 2023
EISAI SUPPORTS RELIEF EFFORTS FOR EARTHQUAKE IN TURKEY AND SYRIA
-
July 15, 2022
Notification Regarding U.S. Research and Development Subsidiary
-
April 1, 2022
-
November 24, 2021
Sustainability
29 countries 2.13 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of March 2023)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
